financetom
Business
financetom
/
Business
/
Boot Barn Stock Falls After Q3 Report: What To Know
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
Boot Barn Stock Falls After Q3 Report: What To Know
Jan 30, 2025 3:04 PM

Boot Barn Holdings, Inc. ( BOOT ) reported its third-quarter financial results after Thursday's closing bell. Here's a look at the details from the report. 

The Details: Boot Barn ( BOOT ) reported earnings of $2.43 per share, beating the $2.29 estimate. Quarterly revenue came in at $608.17 million, beating the $607.01 million estimate.

Same-store sales increased 8.6% compared to the prior-year period, comprised of an increase of 8.2% in retail store same-store sales and an increase of 11.1% in e-commerce same-store sales. The company opened 13 new stores, bringing its total store count to 438 as of the quarter end.

Read Next: 64 Killed In American Airlines Midair Collision Near D.C., Worst US Air Disaster Since 2001 

“I want to thank the entire Boot Barn ( BOOT ) team for their excellent execution and dedication during a busy holiday season, which resulted in strong third-quarter results and earnings per diluted share above the high end of our guidance range. The strength we saw in the business was once again driven by broad-based growth across all major merchandise categories, channels and geographies, resulting in a consolidated same-store sales increase of 8.6%,” said John Hazen, Interim CEO.

“We also grew total sales 16.9% compared to the prior-year period, driven in part by the 13 new stores we opened in the third quarter and the 39 new stores we have opened year-to-date through our third fiscal quarter,” Hazen added.

Outlook: Boot Barn ( BOOT ) raised its fiscal 2025 GAAP EPS guidance from a range of $5.30 to $5.60 to a range of $5.81 to $5.90, versus the $5.76 estimate, and raised its fiscal 2025 sales guidance from a range of $1.87 billion to $1.91 billion to a range of $1.91 billion to $1.92 billion, versus the $1.91 billion estimate.

BOOT Price Action: According to data from Benzinga Pro, Boot Barn Holdings ( BOOT ) shares are down 6.60% after-hours at $163 on Thursday.  

Read Next: 

Microsoft Shares Slide After Q2 Results, Cloud Revenue Misses Expectations: Details 

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
Apple's Launch of iPhone SE4 Not Seen Impacting Revenue Guidance, UBS Says
Apple's Launch of iPhone SE4 Not Seen Impacting Revenue Guidance, UBS Says
Feb 18, 2025
10:22 AM EST, 02/18/2025 (MT Newswires) -- Apple ( AAPL ) 's launch of the fourth generation of the iPhone SE this week has most likely been taken into account in the company's revenue guidance for the March quarter, UBS said in a Sunday note. UBS analysts said that the average selling price of the iPhone could decline mid-single digits...
After Toronto plane crash, Delta says 19 out of 21 passengers released from hospitals
After Toronto plane crash, Delta says 19 out of 21 passengers released from hospitals
Feb 18, 2025
Feb 18 (Reuters) - Delta Air Lines ( DAL ) said on Tuesday that 19 out of the 21 passengers transported to local hospitals after a Toronto plane crash a day earlier have been released, as officials continue a probe into why the regional jet flipped over upon landing. Investigators from Canada's Transportation Safety Board (TSB) are leading the probe...
-- Definity Financial Brief: BMO Says Operating EPS estimates unchanged post a
-- Definity Financial Brief: BMO Says Operating EPS estimates unchanged post a "Modest" Q4 2024 operating EPS beat on better underwriting income
Feb 18, 2025
10:22 AM EST, 02/18/2025 (MT Newswires) -- Price: 60.29, Change: -1.37, Percent Change: -2.22 ...
Longeveron Cellular Therapy Granted International Non-Proprietary Name
Longeveron Cellular Therapy Granted International Non-Proprietary Name
Feb 18, 2025
10:23 AM EST, 02/18/2025 (MT Newswires) -- Longeveron ( LGVN ) said Tuesday that the World Health Organization approved laromestrocel for the non-proprietary name of the company's Lomecel-B cellular therapy. The US Food and Drug Administration granted Lomecel-B regenerative medicine advanced therapy designation and fast track designation to treat mild Alzheimer's disease, and orphan drug designation, fast track designation, and...
Copyright 2023-2025 - www.financetom.com All Rights Reserved